Literature DB >> 33054643

Vertebral insufficiency fractures as a cause of autonomic dysreflexia in a patient with chronic tetraplegia: A case report.

William D White1,2, John T Mansfield1,2, Erika V Gosai2, Suzanne L Groah1,2.   

Abstract

Context: Osteoporosis is a known complication in spinal cord injury patients and can result in an increased risk of fractures and associated morbidity. Bone demineralization is most common in long bones below the level of injury. The pathogenesis is complex and not fully understood.Findings: We present the case of a 65-year-old male with chronic spinal cord injury who was found to have multiple vertebral compression fractures causing autonomic dysreflexia and new onset spasticity.Conclusion/Clinical Relevance: This case illustrates the need for improved awareness, diagnosis, and prevention for this disease process.

Entities:  

Keywords:  Autonomic dysreflexia; Insufficiency fracture; Spinal cord injury; Vertebral fracture

Mesh:

Year:  2020        PMID: 33054643      PMCID: PMC9542342          DOI: 10.1080/10790268.2020.1829421

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   2.040


  14 in total

1.  Longitudinal study of bone turnover after acute spinal cord injury.

Authors:  D Roberts; W Lee; R C Cuneo; J Wittmann; G Ward; R Flatman; B McWhinney; P E Hickman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

Review 2.  Vertebroplasty and Kyphoplasty for Osteoporotic Vertebral Fractures: What Are the Latest Data?

Authors:  R V Chandra; J Maingard; H Asadi; L-A Slater; T-L Mazwi; S Marcia; J Barr; J A Hirsch
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-23       Impact factor: 3.825

Review 3.  Osteoporosis after spinal cord injury.

Authors:  Sheng-Dan Jiang; Li-Yang Dai; Lei-Sheng Jiang
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

4.  Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.

Authors:  L Gifre; J Vidal; J L Carrasco; A Muxi; E Portell; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2015-09-30       Impact factor: 4.507

Review 5.  Vertebral compression fractures in the elderly.

Authors:  Jerry L Old; Michelle Calvert
Journal:  Am Fam Physician       Date:  2004-01-01       Impact factor: 3.292

Review 6.  Osteoporosis in individuals with spinal cord injury.

Authors:  William A Bauman; Christopher P Cardozo
Journal:  PM R       Date:  2014-08-27       Impact factor: 2.298

7.  Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  William Clark; Paul Bird; Peter Gonski; Terrence H Diamond; Peter Smerdely; H Patrick McNeil; Glen Schlaphoff; Carl Bryant; Elizabeth Barnes; Val Gebski
Journal:  Lancet       Date:  2016-08-17       Impact factor: 79.321

8.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Javier San Martin; Michael R McClung; Ethel S Siris; Richard Eastell; Ian R Reid; Pierre Delmas; Holly B Zoog; Matt Austin; Andrea Wang; Stepan Kutilek; Silvano Adami; Jose Zanchetta; Cesar Libanati; Suresh Siddhanti; Claus Christiansen
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

9.  Bone biomarkers in patients with chronic traumatic spinal cord injury.

Authors:  Hadis Sabour; Abbas Norouzi Javidan; Sahar Latifi; Bagher Larijani; Farzad Shidfar; Mohammad Reza Vafa; Ramin Heshmat; Hassan Emami Razavi
Journal:  Spine J       Date:  2013-10-17       Impact factor: 4.166

10.  Relationships between T-scores at the hip and bone mineral density at the distal femur and proximal tibia in persons with spinal cord injury.

Authors:  Christopher M Cirnigliaro; J Scott Parrott; Mary Jane Myslinski; Pierre Asselin; Alexander T Lombard; Michael F La Fountaine; Steven C Kirshblum; Gail F Forrest; Trevor Dyson-Hudson; Ann M Spungen; William A Bauman
Journal:  J Spinal Cord Med       Date:  2019-10-30       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.